NUNZIA PHARMACEUTICAL Co
company.status.inactiveCIK 886093fmd_0A03KESG8DE4G0Y53C113AMAKKManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2022, 26 periods
Latest annual · FY2021
Millions- Total revenues
- 0
- Operating income
- (78)
- Net income
- (78)
Latest quarter · Q3 FY2022
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- n/m
- Revenue, 5 yearsFY2015 to FY2021
- n/m
- Net income, 5 yearsFY2015 to FY2021
- n/m
NUNZIA PHARMACEUTICAL Co financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2022-04-15 · proof | |
| Operating income | -$78.1 million | -$39,327 | 10-K 2022-04-15 · proof | |
| Net income | -$78.1 million | -$101 million | 10-K 2022-04-15 · proof | |
| Cash from operating activities | -$86,776 | -$32,294 | 10-K 2022-04-15 · proof | |
| Total assets | $5,131 | $0 | 10-K 2022-04-15 · proof | |
| Total liabilities | $99,305 | $59,404 | +67.2% | 10-K 2022-04-15 · proof |
| Cash and cash equivalents | $131 | $0 | 10-K 2022-04-15 · proof |
- What was NUNZIA PHARMACEUTICAL Co's revenue in fiscal 2021?
- NUNZIA PHARMACEUTICAL Co reported revenue of $0 for fiscal 2021 (the year ended Dec 31, 2021), against $0 the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What was NUNZIA PHARMACEUTICAL Co's operating income in fiscal 2021?
- NUNZIA PHARMACEUTICAL Co reported operating income of -$78.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$39,327 the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What was NUNZIA PHARMACEUTICAL Co's net income in fiscal 2021?
- NUNZIA PHARMACEUTICAL Co reported net income of -$78.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$101 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What was NUNZIA PHARMACEUTICAL Co's cash from operating activities in fiscal 2021?
- NUNZIA PHARMACEUTICAL Co reported cash from operating activities of -$86,776 for fiscal 2021 (the year ended Dec 31, 2021), against -$32,294 the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What are NUNZIA PHARMACEUTICAL Co's total assets?
- As of Dec 31, 2021, NUNZIA PHARMACEUTICAL Co reported total assets of $5,131, against $0 a year earlier. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What are NUNZIA PHARMACEUTICAL Co's total liabilities?
- As of Dec 31, 2021, NUNZIA PHARMACEUTICAL Co reported total liabilities of $99,305, against $59,404 a year earlier (+67.2%). Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
- What are NUNZIA PHARMACEUTICAL Co's cash and cash equivalents?
- As of Dec 31, 2021, NUNZIA PHARMACEUTICAL Co reported cash and cash equivalents of $131, against $0 a year earlier. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:886093&period_type=annual&limit=5"Information only, not investment advice.